1. Branded Generics Market to reach $536.2 million by 2030 Globally, at a CAGR of 7.3%, says Coherent Market Insights
- Subjects
Retail industry -- Forecasts and trends -- Reports ,Distribution channels -- Forecasts and trends -- Reports ,Antidepressants -- Marketing -- Forecasts and trends -- Reports ,Generic drugs -- Reports -- Marketing -- Forecasts and trends ,Patient compliance -- Forecasts and trends -- Reports ,Antimetabolites -- Reports -- Forecasts and trends -- Marketing ,Gastrointestinal diseases -- Forecasts and trends -- Reports ,Hypertension -- Forecasts and trends -- Reports ,Brand equity -- Forecasts and trends -- Reports ,Pharmacy -- Forecasts and trends -- Reports -- Marketing ,Antipsychotic drugs -- Forecasts and trends -- Reports ,Antihypertensive drugs -- Reports -- Forecasts and trends ,Anticholesteremic agents -- Forecasts and trends -- Marketing -- Reports ,Company marketing practices ,Direct market channel ,Retail/reseller channel ,Market trend/market analysis ,Banking, finance and accounting industries ,Business - Abstract
Burlingame, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled,' Branded Generics Market, By Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, [...]
- Published
- 2023